EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Clinical Efficacy of Levocarnitine-Alprostadil Combination Therapy on Indicators of Renal Function, Oxidant-Antioxidant Balance, and Systemic Inflammation in Patients with End-Stage Diabetic Nephropathy

Li Cheng, Sheng Wan, Yonglong Min, Can Tu, Dongdong Mao, Quan Wang, Shuai Fu, Fei Xiong

Therapeutics and Clinical Risk Management · 2026-02 · Volume 22 · 1-10

DOI: 10.2147/tcrm.s553649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2026-02. Verfasst von Li Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Wuhan No.1 Hospital, Wuhan, 430022, People's Republic of China. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

alprostadilend-stage diabetic nephropathyinflammatory responselevocarnitineoxidative stressrenal function

Autor:innen und Institutionen

  • Department of Nephrology, Wuhan No.1 Hospital, Wuhan, 430022, People's Republic of China.

Zitieren

APA

Cheng, L., Wan, S., Min, Y., Tu, C., Mao, D., Wang, Q., Fu, S., & Xiong, F. (2026). Clinical Efficacy of Levocarnitine-Alprostadil Combination Therapy on Indicators of Renal Function, Oxidant-Antioxidant Balance, and Systemic Inflammation in Patients with End-Stage Diabetic Nephropathy. Therapeutics and Clinical Risk Management, Volume 22, 1-10. https://doi.org/10.2147/tcrm.s553649

Vancouver

Cheng L, Wan S, Min Y, Tu C, Mao D, Wang Q, et al. Clinical Efficacy of Levocarnitine-Alprostadil Combination Therapy on Indicators of Renal Function, Oxidant-Antioxidant Balance, and Systemic Inflammation in Patients with End-Stage Diabetic Nephropathy. Therapeutics and Clinical Risk Management. 2026;Volume 22:1-10. doi:10.2147/tcrm.s553649

BibTeX
@article{Cheng2026,
  author = {Cheng, Li and Wan, Sheng and Min, Yonglong and Tu, Can and Mao, Dongdong and Wang, Quan and Fu, Shuai and Xiong, Fei},
  title = {Clinical Efficacy of Levocarnitine-Alprostadil Combination Therapy on Indicators of Renal Function, Oxidant-Antioxidant Balance, and Systemic Inflammation in Patients with End-Stage Diabetic Nephropathy},
  journal = {Therapeutics and Clinical Risk Management},
  year = {2026},
  volume = {Volume 22},
  pages = {1--10},
  doi = {10.2147/tcrm.s553649}
}
Kostenlos starten →